GDF15 and steatosis: GDF15-knockout mice exhibited aggravated NAFLD phenotypes such as increased steatosis, hepatic inflammation, fibrosis, liver injury, and metabolic deterioration [49] and expression of hepatic Gdf15 reduced lipid accumulation in liver and NAFLD progression [50].